Our clients are pharmaceutical companies who want to start or enhance their export activity. Apexfarma has the role of an outsorced export department covering emerging markets with high development potential.

Our client portfolio is composed by both large companies having strong R+D capabilities and smaller companies having attractive and competitive products.

Last year (2017) Apexfarma achieved an export turnover for our principals of more than 33 Million Euros FOB.